Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
clinical trials
3
×
indiana blog main
life sciences
national blog main
new york blog main
raleigh-durham blog main
3
×
san diego blog main
san francisco blog main
seattle blog main
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
diabetes
fda
indiana top stories
investing
national
national top stories
new york top stories
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle top stories
texas blog main
texas top stories
type 1 diabetes
venture capital
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
What
patients
3
×
drug
market
advantages
bar
beta
bio
bionics
blood
brings
cancer
closed
developing
device
diabetes
driven
eisai
expect
fda
flags
gamble
heads
higher
incidence
key
levels
lorcaserin
loss
manages
marketing
medco’s
medical
medicine
million
monitors
mover
new
pancreas
payers
physicians
Language
unset
Current search:
patients
×
biotech
×
" raleigh-durham blog main "
×
" clinical trials "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests